Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations (Q42221260)

18 October 2017

Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations (English)

1 reference

chronic obstructive pulmonary disease

18 October 2017

1 reference

Charles S Berenson

1

1 reference

18 October 2017

Ragina L Kruzel

2

1 reference

18 October 2017

Ellana Eberhardt

3

1 reference

18 October 2017

Ree Dolnick

4

1 reference

18 October 2017

Hans Minderman

5

1 reference

18 October 2017

Paul K Wallace

6

1 reference

18 October 2017

Sanjay Sethi

7

1 reference

18 October 2017

language of work or name

English

0 references

publication date

31 March 2014

1 reference

18 October 2017

1 reference

18 October 2017

69

1 reference

18 October 2017

9

1 reference

18 October 2017

811-818

1 reference

Chronic obstructive pulmonary disease

18 October 2017

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Moraxella catarrhalis, a human respiratory tract pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Exacerbations: etiology and pathophysiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-203669

10.1136/THORAXJNL-2013-203669

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference